No Recent News for the Company
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
27-Apr-2026 | Source : BSEFormat of Initial Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Clinitech Laboratory Ltd |
| 2 | CIN NO. | L85195MH2010PLC201078 |
| 3 | Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) | 0.36 |
| 4 | Highest Credit Rating during the previous FY | NA |
| 4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | Not Applicable |
| 5 | Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework | BSE |
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No
Name of the Company Secretary: Shruti Patankar
Designation: Company Secretary
EmailId: compliance@clinitechlab.com
Designation: Company Secretary
EmailId: compliance@clinitechlab.com
Name of the Chief Financial Officer: Rahul Patil
Designation: CFO
EmailId: cfo@clinitechlab.com
Designation: CFO
EmailId: cfo@clinitechlab.com
Date: 27/04/2026
Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
General Update W.R.T Memorandum Of Understanding (MOU)
25-Apr-2026 | Source : BSEThis is to inform that the company has entered into Memorandum Of Understanding (MOU) dated 25th April 2026 with M/s. MD Plus Multispeciality Clinic
Non-Applicability Of Reg 23 Of SEBI (LODR) Regulations 2015 W.R.T Related Party Transaction
22-Apr-2026 | Source : BSEUndertaking for non-applicability of disclosure under Reg 23 of SEBI (LODR) Regulations 2015 w.r.t related party transaction.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






